Skip Navigation LinksHome page > Le prove scientifiche > Bibliografia studi clinici

Bibliografia studi clinici

Studi clinici

  • [1. Agarwal KN, Bhasin SK, Faridi MM et al. Lactobacillus casei in the control of acute diarrhea—a pilot study. Indian Pediatr 2001;38(8):905-10.
  • [2. Agarwal KN, Bhasin SK. Feasibility studies to control acute diarrhoea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur J Clin Nutr 2002;56 Suppl 4:S56-S59.
  • [3. Giovannini M, Agostoni C, Riva E et al. A Randomized Prospective Double Blind Controlled Trial on Effects of Long-Term Consumption of Fermented Milk Containing Lactobacillus casei in Pre-School Children With Allergic Asthma and/or Rhinitis. Pediatr res 2007;(epub: 25 6 2007).
  • [4. Guerin-Danan C, Chabanet C, Pedone C et al. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Cli Nutr 1998;67(1):111-7.
  • [5. Hickson M, D’Souza AL, Muthu N et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007;335(7610):80-5.
  • [6. Marcos A, Warnberg J, Nova E et al. The effect of milk fermented by yogurt cultures plus Lactobacillus casei DN-114001 on the immune response of subjects under academic examination stress. Eur J Nutr 2004;43(6):381-9.
  • [7. Meyer AL, Micksche M, Herbacek I et al. Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women. Ann Nutr Metab 2006;50(3):282-9.
  • [8. Oozeer R, Leplingard A, Mater DD et al. Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol 2006;72(8):5615-7.
  • [9. Parra MD, Martinez de Morentin BE, Cobo JM et al. Monocyte function in healthy middle-aged people receiving fermented milk containing Lactobacillus casei. J Nutr Health Aging 2004;8(4):208-11.
  • [10. Parra MD, Martinez de Morentin BE, Cobo JM et al. Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J Physiol Biochem 2004;60(2):85-91.
  • [11. Pedone CA, Bernabeu AO, Postaire ER et al. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999;53(3):179-84.
  • [12. Pedone CA, Arnaud CC, Postaire ER et al. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract 2000;54(9):568-71.
  • [13. Pereg D, Kimhi O, Tirosh A et al. The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. Am J Infect Control 2005;33(2):122-5.
  • [14. Pujol P, Huguet J, Drobnic F et al. The effect of fermented milk containing Lactobacillus casei in the immune response to exercise. Training Rehab 2000;9(3):209-23.
  • [15. Rochet V, Rigottier-Gois L, Sutren M et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr 2006;95(2):421-9.
  • [16. Sykora J, Valeková K, Amlerová J et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005;39(8):692-8.
  • [17. Tiollier E, Gomez-Merino D, Burnat P, Jouanin JC, Bourrilhon C, Filaire E, Guezennec CY, Chennaoui M. Intense training: mucosal immunity and incidence of respiratory infections.Eur J Appl Physiol. 2005 Jan;93(4):421-8.
  • [18. Turchet P, Laurenzano M, Auboiron S et al. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114 001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003;7(2):75-7.
 

Pubblicazioni a supporto: studi in vitro e in vivo

  • [1. Borruel N, Carol M, Casellas F et al. Increased mucosal tumour necrosis factor alpha production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria. Gut 2002;51(5):659-64.
  • [2. Borruel N, Casellas F, Antolin M et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 2003;98(4):865-70.
  • [3. Carol M, Borruel N, Antolin M et al. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn’s disease. J Leukoc Biol 2006;79(5):917-22.
  • [4. Chapat L, Chemin K, Dubois B et al. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol 2004;34(9):2520-8.
  • [5. Diancourt L, Passet V, Chervaux C et al. Multilocus Sequence Typing of Lactobacillus casei Reveals a Clonal Population Structure with Low Levels of Homologous Recombination. Appl Environ Microbiol 2007;73(20):6601-11.
  • [6. Djouzi Z, Andrieux C, Degivry MC et al. The association of yogurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats. J Nutr 1997;127(11):2260-6.
  • [7. Fayol-Messaoudi D, Berger CN, Coconnier-Polter MH et al. pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol 2005;71(10):6008-13.
  • [8. Freitas M, Tavan E, Cayuela C et al. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol Cell 2003;95(8):503-6.
  • [9. Guerin-Danan C, Meslin JC, Chambard A et al. Food supplementation with milk fermented by Lactobacillus casei DN-114 001 protects suckling rats from rotavirus-associated diarrhea. J Nutr 2001;131(1):111-7.
  • [10. Guitard J, Menotti J, Desveaux A et al. Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats. Parasitol Res 2006;99(5):522-7.
  • [11. Ingrassia I, Leplingard A, Darfeuille-Michaud A. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn’s disease patients to adhere to and to invade intestinal epithelial cells. Appl Environ Microbiol 2005;71(6):2880-7.
  • [13. Llopis M, Antolin M, Guarner F et al. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid. Gut 2005;54(7):955-9.
  • [14. Medici M, Vinderola CG, Weill R et al. Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice. J Dairy Res 2005;72(2):243-9.
  • [15. Oozeer R, Goupil-Feuillerat N, Alpert CA et al. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl Environ Microbiol 2002;68(7):3570-4.
  • [16. Oozeer R, Mater DD, Goupil-Feuillerat N et al. Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota. Appl Environ Microbiol 2004;70(12):6992-7.
  • [17. Oozeer R, Furet JP, Goupil-Feuillerat N et al. Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice. Appl Environ Microbiol 2005;71(3):1356-63.
  • [18. Parassol N, Freitas M, Thoreux K et al. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 2005;156(2):256-62.
  • [19. Paubert-Braquet M, Xiao HG, Gaudichon C et al. Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with yogurt or milks fermented with various Lactobacillus casei strains. Int J immunother 1995;11(4):153-61.
  • [20. Portier A, Boyaka NP, Bougoudogo F et al. Fermented milks and increased antibody responses against cholera in mice. Int J Immunotherapy 1993;9(4):217-24.
  • [21. Tanabe H, Shirafuji Y, Thoreux K et al. Lactobacillus casei DN- 114 001 induces Paneth cell secretion and is sensitive to enteric Gastroenterology 2004;126(4 (S2)):A578.       
  • [22. Tien MT, Girardin SE, Regnault B et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 2006;176(2):1228-37.